Epstein Becker Green (“EBG”) has previously advised U.S. organizations that share data in bulk or otherwise grant access to U.S. sensitive data to countries of concern or covered persons to “Know Their Data” and “Know Their Vendors.” In this post, we discuss why U.S. organizations across all industries with cross-border operations – including health care / life sciences, finance, e-commerce, and research – must “know their reporting requirements,” to fully comply with the BSD Rule and its brand-new reporting obligations.
Recent Updates
- When AI Becomes Part of Medicine: Why CMS’s AI Questions Matter Now
- Watch: Gender-Affirming Care: What Health Care Providers Need to Know About Federal Enforcement – Thought Leaders in Health Law
- Executive Order 14321 at One Year: Civil Commitment Policy Shifts and Provider Impact
- Watch: FDA’s 2026 Enforcement Priorities: What In-House Counsel Must Know – Thought Leaders in Health Law
- The Future of 340B: New Bills Offer Competing Solutions to Modernize the 340B Drug Discount Program